HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Binder Selected Research

C Binder Research Topics

Disease

5Breast Neoplasms (Breast Cancer)
03/2011 - 09/2002
3Neoplasm Metastasis (Metastasis)
04/2013 - 09/2002
3Neoplasms (Cancer)
04/2006 - 05/2000
2Infections
11/2013 - 01/2000
2Brain Neoplasms (Brain Tumor)
04/2013 - 03/2011
1Herpes Zoster
01/2021
1Neutropenia
11/2013
1Lymphoma (Lymphomas)
11/2013
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2013
1Adenocarcinoma
04/2013
1Adenocarcinoma of Lung
04/2013
1Food Hypersensitivity (Food Allergy)
07/2005
1Mycoses (Diseases, Fungus)
02/2003
1Inflammation (Inflammations)
02/2003
1Renal Cell Carcinoma (Grawitz Tumor)
10/2001
1Carcinoma (Carcinomatosis)
10/2001
1Atopic Dermatitis (Atopic Eczema)
04/2001
1Milk Hypersensitivity (Milk Allergy)
04/2001
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2001
1Disease Progression
01/2001
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2001
1Pancytopenia
01/2001
1Retinal Perforations
12/2000
1Tachycardia (Tachyarrhythmias)
11/2000
1Anticholinergic Syndrome
11/2000
1Confusion (Bewilderment)
11/2000
1Coma (Comas)
11/2000
1Sleepiness
11/2000
1Dyspepsia (Indigestion)
10/2000
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2000
1Ulcerative Colitis
09/2000
1Crohn Disease (Crohn's Disease)
09/2000
1Carcinogenesis
05/2000

Drug/Important Bio-Agent (IBA)

3Metalloproteases (Metalloproteinases)IBA
04/2006 - 10/2001
3Matrix Metalloproteinases (MMPs)IBA
09/2004 - 10/2001
2CateninsIBA
04/2013 - 03/2011
2RelaxinIBA
09/2004 - 09/2002
1ChromatinIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Alemtuzumab (Campath)FDA Link
11/2013
1Transcription Factors (Transcription Factor)IBA
04/2013
1Phenobarbital (Luminal)FDA Link
03/2011
1Wnt ReceptorsIBA
03/2011
1Hormones (Hormone)IBA
12/2009
1JNK Mitogen-Activated Protein KinasesIBA
04/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2006
1APTIBA
07/2005
1AntibodiesIBA
07/2005
1Immunoglobulin E (IgE)IBA
07/2005
1ProcalcitoninIBA
02/2003
1C-Reactive ProteinIBA
02/2003
1Messenger RNA (mRNA)IBA
10/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2001
1Tissue Inhibitor of Metalloproteinase-2IBA
10/2001
1Tissue Inhibitor of Metalloproteinase-1IBA
10/2001
1Tissue Inhibitor of Metalloproteinase-3IBA
10/2001
1Proteins (Proteins, Gene)FDA Link
04/2001
1Amino AcidsFDA Link
04/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2001
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2001
1Amifostine (Ethyol)FDA LinkGeneric
01/2001
1PhenothiazinesIBA
11/2000
1Psychotropic Drugs (Psychoactive Drugs)IBA
11/2000
1ButyrophenonesIBA
11/2000
1AtropineFDA LinkGeneric
11/2000
1Antidepressive Agents (Antidepressants)IBA
11/2000
1PhysostigmineIBA
11/2000
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2000
1Azathioprine (Imuran)FDA LinkGeneric
09/2000
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
09/2000
1Oxidants (Oxidizing Agents)IBA
05/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2000
1Epidermal Growth Factor (EGF)IBA
05/2000
1AntralIBA
05/2000

Therapy/Procedure

6Therapeutics
11/2013 - 01/2000
2Drug Therapy (Chemotherapy)
02/2001 - 01/2001
1Salvage Therapy
11/2013
1Aftercare (After-Treatment)
11/2013
1Traction
12/2000
1Contraindications
11/2000
1Enteral Nutrition (Feeding, Tube)
09/2000